Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01)

The summary for the Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01): The purpose of this funding opportunity is to identify genetic and epigenetic factors that affect the recovery of the CD4+ T cells in response to anti-retroviral therapy in HIV infected people who inject drugs infected
Federal Grant Title: Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-18-014
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Information not provided
Current Application Deadline: December 14th, 2017
Original Application Deadline: December 14th, 2017
Posted Date: August 3rd, 2017
Creation Date: August 3rd, 2017
Archive Date: January 19th, 2018
Total Program Funding:
Maximum Federal Grant Award: $2,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: August 3rd, 2017
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-014.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Tria...
Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Option...
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
International Research Collaboration on Drug Abuse and Addiction Research (R21 Clinical Tr...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Mentored Research Scientist Development Award (Parent K01 - Clinical Trial Required)
Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial O...
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic...
Mentored Research Scientist Development Award (Parent K01 -Independent Clinical Trial Not ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2017 FederalGrants.com